Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23576343 | 1.00 | ALDH1A1 (0.33) | ALDH1A1EPHX1KDM4ENPC1POLB | |
| SCHEMBL8775683 | 0.86 | ALDH1A1 (0.35) | ALDH1A1EPHX1ATMHPGD | |
| SCHEMBL23576346 | 0.81 | CHRM2 (0.36) | ALDH1A1EPHX1HPGD | |
| SCHEMBL465418 | 0.81 | ALDH1A1 (0.34) | ALDH1A1EPHX1 | |
| SCHEMBL23576350 | 0.81 | CHRM2 (0.36) | ALDH1A1EPHX1HPGD | |
| SCHEMBL1320016 | 0.79 | EPHX1 (0.55) | ALDH1A1EPHX1KDM4EMAPTHPGD | |
| SCHEMBL5354058 | 0.79 | EPHX1 (0.55) | ALDH1A1EPHX1KDM4EMAPTHPGD | |
| SCHEMBL14559200 | 0.79 | EPHX1 (0.55) | ALDH1A1EPHX1KDM4EMAPTHPGD | |
| SCHEMBL23494169 | 0.78 | ALDH1A1 (0.38) | ALDH1A1KDM4ENPC1POLBMAPT | |
| SCHEMBL7794025 | 0.78 | ALDH1A1 (0.30) | ALDH1A1EPHX1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210198229-A1 | FRAGRANCE AND FLAVOR MATERIALS FROM 1-(2-HYDROXY-4-METHYLCYCLOHEXYL)-ETHANONE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210198229-A1 | FRAGRANCE AND FLAVOR MATERIALS FROM 1-(2-HYDROXY-4-METHYLCYCLOHEXYL)-ETHANONE | TAS2R5, TAS2R50, TAS2R20 | ALDH1A1 457/4885EPHX1 765/4885KDM4E 232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.